Stem Cell Science
“From now on, everything I 'm going to talk about is true. Some may be unbelievable, but it's all true. The fact that Shin-ichi Nishikawa, Hitoshi Niwa, and the late Yoshiki Sasai of the stem cell research team of RIKEN, which was the top scientific institution in Japan, was involved has been said to be a big problem. The STAP cell group (Shin-ichi Nishikawa, Hitoshi Niwa, late Yoshiki Sasai) has discovered a fact that is usually not known, that is, a paper forgery fraud executed by the stem cell research team of Science and RIKEN. Another paper-forgery scam that was involved in front of the cell. It's a terrifying world. People who do the terrible things hidden behind the word patient salvation. Is it really a Japanese story?
We have been slandered by nurses at National Defense Medical College Hospital and Douglas Sipp at RIKEN since 2008. It is a slander by the staff of the stem cell research team of RIKEN, the highest institution in the country. The police don't move either. Meanwhile, "The police will not move. I felt it was time for us to talk about the damage we suffered, so we decided to talk about everything.
This is all true.
The fact that the reason why Stemcell Science could not be listed was "due to the fraudulent thesis forging by the former management and RIKEN" was that JAFCO, an investment company affiliated with Nomura Securities, attended the board meeting as an observer. I knew all the facts because I was there. (Recording tape available) JAFCO tells shareholders from his own mouth. However, in order to explain the request for the return of the representative seal, it was the first time from the person in charge at the meeting with JAFCO's managing director that there are still many shareholders who do not know the facts. So, I explained using this homepage.
There is a lot of evidence (recording tapes and proof emails) that is true of what I am saying, but of these, I will only disclose the evidence that an American lawyer has told me to disclose. Others will be disclosed in an American trial.
Stem Cell Science
“From now on, everything I 'm going to talk about is true. Some may be unbelievable, but it's all true. The fact that Shin-ichi Nishikawa, Hitoshi Niwa, and the late Yoshiki Sasai of the stem cell research team of RIKEN, which was the top scientific institution in Japan, was involved has been said to be a big problem. The STAP cell group (Shin-ichi Nishikawa, Hitoshi Niwa, late Yoshiki Sasai) has discovered a fact that is usually not known, that is, a paper forgery fraud executed by the stem cell research team of Science and RIKEN. Another paper-forgery scam that was involved in front of the cell. It's a terrifying world. People who do the terrible things hidden behind the word patient salvation. Is it really a Japanese story?
We have been slandered by nurses at National Defense Medical College Hospital and Douglas Sipp at RIKEN since 2008. It is a slander by the staff of the stem cell research team of RIKEN, the highest institution in the country. The police don't move either. Meanwhile, "The police will not move. I felt it was time for us to talk about the damage we suffered, so we decided to talk about everything.
This is all true.
The fact that the reason why Stemcell Science could not be listed was "due to the fraudulent thesis forging by the former management and RIKEN" was that JAFCO, an investment company affiliated with Nomura Securities, attended the board meeting as an observer. I knew all the facts because I was there. (Recording tape available) JAFCO tells shareholders from his own mouth. However, in order to explain the request for the return of the representative seal, it was the first time from the person in charge at the meeting with JAFCO's managing director that there are still many shareholders who do not know the facts. So, I explained using this homepage.
There is a lot of evidence (recording tapes and proof emails) that is true of what I am saying, but of these, I will only disclose the evidence that an American lawyer has told me to disclose. Others will be disclosed in an American trial.
Stem Cell Science USA
In the email below, we, Shin-ichi Nishikawa, Yoshiki Sasai, Hitoshi Niwa, who were the STAP cell group of Stem Cell Science and RIKEN, collaborated with the Advanced Medical Promotion Foundation to forge clinical data and invest. ANA Continental Hotel in Akasaka on December 24, pursuing the facts about [Stem Cell Science's paper fabrication fraud case] that tricked a house into fraudulently defrauding 300 to 700 million yen (later known to be 700 million yen) This is the email the day after the [Extraordinary Board of Directors Meeting] held in. At the meeting, Audit & Supervisory Board Member Nakahara and Kenzo Nakajima, who attended the telephone call, admitted fraud, so when consulting with a lawyer, they forged to dazzle the clinical trial of myoblast transplantation received from Audit & Supervisory Board Member Nakahara. It will be an email pointing out what was being done.
In the end, I went to consult with three lawyers with these materials, but everyone said, "This is a treatise forgery scam, so you should report it to the police. Otherwise, you will not be listed. It was decided to report to the police on December 28, so I told the auditors Nakahara, Kenzo Nakajima, Yoshiko Nakajima and others to that effect.
December 28th was the day when the eldest son of Mr. and Mrs. Ryan was discharged from the hospital, and Mr. and Mrs. Ryan were planning to celebrate the New Year in Kyoto, so it was decided by Kobe to talk to the police.
However, in reality, on the morning of December 28, the eldest son of Mr. and Mrs. Ryan was murdered at the hospitalized Defense University Hospital, where he was covered with a plastic bag twice on his head and fell from a brain-dead state to a plant-human state. The police report was put on hold because I couldn't go to Kyoto because I was involved in an attempted and unintentional incident.
Click here for more information on the case at National Defense Medical College Hospital
From: From:
Sent: Tuesday, December 25, 2007 10:32 AM
To:'Miki'
Subject: Celogos
Miki
I'm talking about myoblast transplantation. This also states that the goal is to start clinical trials in the second quarter of 2008, and it is the content to mislead shareholders.
There is no reality at all. On the other hand, Mr. Nakahara stated that he was a goal, so he said he didn't feel guilty. It's sad, is not it.
I will send you the clinical trial guide from Pharmaceuticals and Medical Devices Agency and the contents of the file I received from them as an attachment. If you would like to consult with a lawyer today, please refer to this as well.
In addition, hMADS also states that it is planning a clinical trial in the United States in 1-2Q of 2009, and I think it is necessary to confirm whether there are any documents related to it.
Rishi Gojo